Research ArticleArticle
Rheumatic Disease Among Oklahoma Tribal Populations: A Cross-sectional Study
Jasmine R. Gaddy, Evan S. Vista, Julie M. Robertson, Amy B. Dedeke, Virginia C. Roberts, Wendy S. Klein, Jeremy H. Levin, Fabio H. Mota, Tina M. Cooper, Gloria A. Grim, Sohail Khan and Judith A. James
The Journal of Rheumatology August 2012, jrheum.110984; DOI: https://doi.org/10.3899/jrheum.110984
Jasmine R. Gaddy
From the Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City; Division of Rheumatology/ Allergy/Immunology, University of Oklahoma Health Sciences Center, Oklahoma City; Chickasaw National Medical Center, Ada; and the Cherokee Nation Health Services, Tahlequah, Oklahoma, USA. Supported by grants from Native American Research Centers for Health (U26 IHS300412), the Center of Biomedical Research Excellence (P20RR015577 and P30RR031152/P30GM103510), the Oklahoma Rheumatic Disease Research Core Center (P30AR053483), and the Oklahoma Autoimmunity Center of Excellence (U19 AI082714) from the US National Institutes of Health. The contents are the sole responsibility of the authors and do not necessarily represent the official view of the NIH. J.R. Gaddy, MD, Division of Rheumatology/Allergy/Immunology, University of Oklahoma Health Science Center and Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; E.S. Vista, MD, Divisions of Rheumatology, University of Santo Tomas Hospital; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.M. Robertson, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; A.B. Dedeke, MD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; V.C. Roberts, LPN, CCRP, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; W.S. Klein, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.H. Levin, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; F.H. Mota, MD; T.M. Cooper, MD, Chickasaw Nation Medical Center; G.A. Grim, MD; S. Khan, MBBS, MPH, Cherokee Nation Health Services; J.A. James, MD, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation and Departments of Medicine, Pathology, and Microbiology/Immunology, University of Oklahoma Health Sciences Center. Address correspondence to Dr. J.A. James, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA. E-mail: judith-james@omrf.org Accepted for publication June 4, 2012.
Evan S. Vista
From the Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City; Division of Rheumatology/ Allergy/Immunology, University of Oklahoma Health Sciences Center, Oklahoma City; Chickasaw National Medical Center, Ada; and the Cherokee Nation Health Services, Tahlequah, Oklahoma, USA. Supported by grants from Native American Research Centers for Health (U26 IHS300412), the Center of Biomedical Research Excellence (P20RR015577 and P30RR031152/P30GM103510), the Oklahoma Rheumatic Disease Research Core Center (P30AR053483), and the Oklahoma Autoimmunity Center of Excellence (U19 AI082714) from the US National Institutes of Health. The contents are the sole responsibility of the authors and do not necessarily represent the official view of the NIH. J.R. Gaddy, MD, Division of Rheumatology/Allergy/Immunology, University of Oklahoma Health Science Center and Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; E.S. Vista, MD, Divisions of Rheumatology, University of Santo Tomas Hospital; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.M. Robertson, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; A.B. Dedeke, MD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; V.C. Roberts, LPN, CCRP, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; W.S. Klein, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.H. Levin, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; F.H. Mota, MD; T.M. Cooper, MD, Chickasaw Nation Medical Center; G.A. Grim, MD; S. Khan, MBBS, MPH, Cherokee Nation Health Services; J.A. James, MD, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation and Departments of Medicine, Pathology, and Microbiology/Immunology, University of Oklahoma Health Sciences Center. Address correspondence to Dr. J.A. James, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA. E-mail: judith-james@omrf.org Accepted for publication June 4, 2012.
Julie M. Robertson
From the Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City; Division of Rheumatology/ Allergy/Immunology, University of Oklahoma Health Sciences Center, Oklahoma City; Chickasaw National Medical Center, Ada; and the Cherokee Nation Health Services, Tahlequah, Oklahoma, USA. Supported by grants from Native American Research Centers for Health (U26 IHS300412), the Center of Biomedical Research Excellence (P20RR015577 and P30RR031152/P30GM103510), the Oklahoma Rheumatic Disease Research Core Center (P30AR053483), and the Oklahoma Autoimmunity Center of Excellence (U19 AI082714) from the US National Institutes of Health. The contents are the sole responsibility of the authors and do not necessarily represent the official view of the NIH. J.R. Gaddy, MD, Division of Rheumatology/Allergy/Immunology, University of Oklahoma Health Science Center and Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; E.S. Vista, MD, Divisions of Rheumatology, University of Santo Tomas Hospital; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.M. Robertson, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; A.B. Dedeke, MD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; V.C. Roberts, LPN, CCRP, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; W.S. Klein, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.H. Levin, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; F.H. Mota, MD; T.M. Cooper, MD, Chickasaw Nation Medical Center; G.A. Grim, MD; S. Khan, MBBS, MPH, Cherokee Nation Health Services; J.A. James, MD, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation and Departments of Medicine, Pathology, and Microbiology/Immunology, University of Oklahoma Health Sciences Center. Address correspondence to Dr. J.A. James, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA. E-mail: judith-james@omrf.org Accepted for publication June 4, 2012.
Amy B. Dedeke
From the Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City; Division of Rheumatology/ Allergy/Immunology, University of Oklahoma Health Sciences Center, Oklahoma City; Chickasaw National Medical Center, Ada; and the Cherokee Nation Health Services, Tahlequah, Oklahoma, USA. Supported by grants from Native American Research Centers for Health (U26 IHS300412), the Center of Biomedical Research Excellence (P20RR015577 and P30RR031152/P30GM103510), the Oklahoma Rheumatic Disease Research Core Center (P30AR053483), and the Oklahoma Autoimmunity Center of Excellence (U19 AI082714) from the US National Institutes of Health. The contents are the sole responsibility of the authors and do not necessarily represent the official view of the NIH. J.R. Gaddy, MD, Division of Rheumatology/Allergy/Immunology, University of Oklahoma Health Science Center and Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; E.S. Vista, MD, Divisions of Rheumatology, University of Santo Tomas Hospital; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.M. Robertson, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; A.B. Dedeke, MD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; V.C. Roberts, LPN, CCRP, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; W.S. Klein, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.H. Levin, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; F.H. Mota, MD; T.M. Cooper, MD, Chickasaw Nation Medical Center; G.A. Grim, MD; S. Khan, MBBS, MPH, Cherokee Nation Health Services; J.A. James, MD, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation and Departments of Medicine, Pathology, and Microbiology/Immunology, University of Oklahoma Health Sciences Center. Address correspondence to Dr. J.A. James, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA. E-mail: judith-james@omrf.org Accepted for publication June 4, 2012.
Virginia C. Roberts
From the Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City; Division of Rheumatology/ Allergy/Immunology, University of Oklahoma Health Sciences Center, Oklahoma City; Chickasaw National Medical Center, Ada; and the Cherokee Nation Health Services, Tahlequah, Oklahoma, USA. Supported by grants from Native American Research Centers for Health (U26 IHS300412), the Center of Biomedical Research Excellence (P20RR015577 and P30RR031152/P30GM103510), the Oklahoma Rheumatic Disease Research Core Center (P30AR053483), and the Oklahoma Autoimmunity Center of Excellence (U19 AI082714) from the US National Institutes of Health. The contents are the sole responsibility of the authors and do not necessarily represent the official view of the NIH. J.R. Gaddy, MD, Division of Rheumatology/Allergy/Immunology, University of Oklahoma Health Science Center and Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; E.S. Vista, MD, Divisions of Rheumatology, University of Santo Tomas Hospital; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.M. Robertson, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; A.B. Dedeke, MD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; V.C. Roberts, LPN, CCRP, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; W.S. Klein, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.H. Levin, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; F.H. Mota, MD; T.M. Cooper, MD, Chickasaw Nation Medical Center; G.A. Grim, MD; S. Khan, MBBS, MPH, Cherokee Nation Health Services; J.A. James, MD, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation and Departments of Medicine, Pathology, and Microbiology/Immunology, University of Oklahoma Health Sciences Center. Address correspondence to Dr. J.A. James, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA. E-mail: judith-james@omrf.org Accepted for publication June 4, 2012.
Wendy S. Klein
From the Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City; Division of Rheumatology/ Allergy/Immunology, University of Oklahoma Health Sciences Center, Oklahoma City; Chickasaw National Medical Center, Ada; and the Cherokee Nation Health Services, Tahlequah, Oklahoma, USA. Supported by grants from Native American Research Centers for Health (U26 IHS300412), the Center of Biomedical Research Excellence (P20RR015577 and P30RR031152/P30GM103510), the Oklahoma Rheumatic Disease Research Core Center (P30AR053483), and the Oklahoma Autoimmunity Center of Excellence (U19 AI082714) from the US National Institutes of Health. The contents are the sole responsibility of the authors and do not necessarily represent the official view of the NIH. J.R. Gaddy, MD, Division of Rheumatology/Allergy/Immunology, University of Oklahoma Health Science Center and Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; E.S. Vista, MD, Divisions of Rheumatology, University of Santo Tomas Hospital; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.M. Robertson, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; A.B. Dedeke, MD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; V.C. Roberts, LPN, CCRP, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; W.S. Klein, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.H. Levin, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; F.H. Mota, MD; T.M. Cooper, MD, Chickasaw Nation Medical Center; G.A. Grim, MD; S. Khan, MBBS, MPH, Cherokee Nation Health Services; J.A. James, MD, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation and Departments of Medicine, Pathology, and Microbiology/Immunology, University of Oklahoma Health Sciences Center. Address correspondence to Dr. J.A. James, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA. E-mail: judith-james@omrf.org Accepted for publication June 4, 2012.
Jeremy H. Levin
From the Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City; Division of Rheumatology/ Allergy/Immunology, University of Oklahoma Health Sciences Center, Oklahoma City; Chickasaw National Medical Center, Ada; and the Cherokee Nation Health Services, Tahlequah, Oklahoma, USA. Supported by grants from Native American Research Centers for Health (U26 IHS300412), the Center of Biomedical Research Excellence (P20RR015577 and P30RR031152/P30GM103510), the Oklahoma Rheumatic Disease Research Core Center (P30AR053483), and the Oklahoma Autoimmunity Center of Excellence (U19 AI082714) from the US National Institutes of Health. The contents are the sole responsibility of the authors and do not necessarily represent the official view of the NIH. J.R. Gaddy, MD, Division of Rheumatology/Allergy/Immunology, University of Oklahoma Health Science Center and Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; E.S. Vista, MD, Divisions of Rheumatology, University of Santo Tomas Hospital; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.M. Robertson, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; A.B. Dedeke, MD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; V.C. Roberts, LPN, CCRP, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; W.S. Klein, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.H. Levin, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; F.H. Mota, MD; T.M. Cooper, MD, Chickasaw Nation Medical Center; G.A. Grim, MD; S. Khan, MBBS, MPH, Cherokee Nation Health Services; J.A. James, MD, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation and Departments of Medicine, Pathology, and Microbiology/Immunology, University of Oklahoma Health Sciences Center. Address correspondence to Dr. J.A. James, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA. E-mail: judith-james@omrf.org Accepted for publication June 4, 2012.
Fabio H. Mota
From the Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City; Division of Rheumatology/ Allergy/Immunology, University of Oklahoma Health Sciences Center, Oklahoma City; Chickasaw National Medical Center, Ada; and the Cherokee Nation Health Services, Tahlequah, Oklahoma, USA. Supported by grants from Native American Research Centers for Health (U26 IHS300412), the Center of Biomedical Research Excellence (P20RR015577 and P30RR031152/P30GM103510), the Oklahoma Rheumatic Disease Research Core Center (P30AR053483), and the Oklahoma Autoimmunity Center of Excellence (U19 AI082714) from the US National Institutes of Health. The contents are the sole responsibility of the authors and do not necessarily represent the official view of the NIH. J.R. Gaddy, MD, Division of Rheumatology/Allergy/Immunology, University of Oklahoma Health Science Center and Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; E.S. Vista, MD, Divisions of Rheumatology, University of Santo Tomas Hospital; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.M. Robertson, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; A.B. Dedeke, MD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; V.C. Roberts, LPN, CCRP, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; W.S. Klein, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.H. Levin, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; F.H. Mota, MD; T.M. Cooper, MD, Chickasaw Nation Medical Center; G.A. Grim, MD; S. Khan, MBBS, MPH, Cherokee Nation Health Services; J.A. James, MD, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation and Departments of Medicine, Pathology, and Microbiology/Immunology, University of Oklahoma Health Sciences Center. Address correspondence to Dr. J.A. James, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA. E-mail: judith-james@omrf.org Accepted for publication June 4, 2012.
Tina M. Cooper
From the Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City; Division of Rheumatology/ Allergy/Immunology, University of Oklahoma Health Sciences Center, Oklahoma City; Chickasaw National Medical Center, Ada; and the Cherokee Nation Health Services, Tahlequah, Oklahoma, USA. Supported by grants from Native American Research Centers for Health (U26 IHS300412), the Center of Biomedical Research Excellence (P20RR015577 and P30RR031152/P30GM103510), the Oklahoma Rheumatic Disease Research Core Center (P30AR053483), and the Oklahoma Autoimmunity Center of Excellence (U19 AI082714) from the US National Institutes of Health. The contents are the sole responsibility of the authors and do not necessarily represent the official view of the NIH. J.R. Gaddy, MD, Division of Rheumatology/Allergy/Immunology, University of Oklahoma Health Science Center and Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; E.S. Vista, MD, Divisions of Rheumatology, University of Santo Tomas Hospital; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.M. Robertson, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; A.B. Dedeke, MD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; V.C. Roberts, LPN, CCRP, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; W.S. Klein, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.H. Levin, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; F.H. Mota, MD; T.M. Cooper, MD, Chickasaw Nation Medical Center; G.A. Grim, MD; S. Khan, MBBS, MPH, Cherokee Nation Health Services; J.A. James, MD, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation and Departments of Medicine, Pathology, and Microbiology/Immunology, University of Oklahoma Health Sciences Center. Address correspondence to Dr. J.A. James, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA. E-mail: judith-james@omrf.org Accepted for publication June 4, 2012.
Gloria A. Grim
From the Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City; Division of Rheumatology/ Allergy/Immunology, University of Oklahoma Health Sciences Center, Oklahoma City; Chickasaw National Medical Center, Ada; and the Cherokee Nation Health Services, Tahlequah, Oklahoma, USA. Supported by grants from Native American Research Centers for Health (U26 IHS300412), the Center of Biomedical Research Excellence (P20RR015577 and P30RR031152/P30GM103510), the Oklahoma Rheumatic Disease Research Core Center (P30AR053483), and the Oklahoma Autoimmunity Center of Excellence (U19 AI082714) from the US National Institutes of Health. The contents are the sole responsibility of the authors and do not necessarily represent the official view of the NIH. J.R. Gaddy, MD, Division of Rheumatology/Allergy/Immunology, University of Oklahoma Health Science Center and Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; E.S. Vista, MD, Divisions of Rheumatology, University of Santo Tomas Hospital; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.M. Robertson, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; A.B. Dedeke, MD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; V.C. Roberts, LPN, CCRP, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; W.S. Klein, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.H. Levin, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; F.H. Mota, MD; T.M. Cooper, MD, Chickasaw Nation Medical Center; G.A. Grim, MD; S. Khan, MBBS, MPH, Cherokee Nation Health Services; J.A. James, MD, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation and Departments of Medicine, Pathology, and Microbiology/Immunology, University of Oklahoma Health Sciences Center. Address correspondence to Dr. J.A. James, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA. E-mail: judith-james@omrf.org Accepted for publication June 4, 2012.
Sohail Khan
From the Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City; Division of Rheumatology/ Allergy/Immunology, University of Oklahoma Health Sciences Center, Oklahoma City; Chickasaw National Medical Center, Ada; and the Cherokee Nation Health Services, Tahlequah, Oklahoma, USA. Supported by grants from Native American Research Centers for Health (U26 IHS300412), the Center of Biomedical Research Excellence (P20RR015577 and P30RR031152/P30GM103510), the Oklahoma Rheumatic Disease Research Core Center (P30AR053483), and the Oklahoma Autoimmunity Center of Excellence (U19 AI082714) from the US National Institutes of Health. The contents are the sole responsibility of the authors and do not necessarily represent the official view of the NIH. J.R. Gaddy, MD, Division of Rheumatology/Allergy/Immunology, University of Oklahoma Health Science Center and Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; E.S. Vista, MD, Divisions of Rheumatology, University of Santo Tomas Hospital; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.M. Robertson, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; A.B. Dedeke, MD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; V.C. Roberts, LPN, CCRP, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; W.S. Klein, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.H. Levin, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; F.H. Mota, MD; T.M. Cooper, MD, Chickasaw Nation Medical Center; G.A. Grim, MD; S. Khan, MBBS, MPH, Cherokee Nation Health Services; J.A. James, MD, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation and Departments of Medicine, Pathology, and Microbiology/Immunology, University of Oklahoma Health Sciences Center. Address correspondence to Dr. J.A. James, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA. E-mail: judith-james@omrf.org Accepted for publication June 4, 2012.
Judith A. James
From the Department of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City; Division of Rheumatology/ Allergy/Immunology, University of Oklahoma Health Sciences Center, Oklahoma City; Chickasaw National Medical Center, Ada; and the Cherokee Nation Health Services, Tahlequah, Oklahoma, USA. Supported by grants from Native American Research Centers for Health (U26 IHS300412), the Center of Biomedical Research Excellence (P20RR015577 and P30RR031152/P30GM103510), the Oklahoma Rheumatic Disease Research Core Center (P30AR053483), and the Oklahoma Autoimmunity Center of Excellence (U19 AI082714) from the US National Institutes of Health. The contents are the sole responsibility of the authors and do not necessarily represent the official view of the NIH. J.R. Gaddy, MD, Division of Rheumatology/Allergy/Immunology, University of Oklahoma Health Science Center and Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; E.S. Vista, MD, Divisions of Rheumatology, University of Santo Tomas Hospital; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.M. Robertson, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; A.B. Dedeke, MD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; V.C. Roberts, LPN, CCRP, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; W.S. Klein, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; J.H. Levin, BS, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation; F.H. Mota, MD; T.M. Cooper, MD, Chickasaw Nation Medical Center; G.A. Grim, MD; S. Khan, MBBS, MPH, Cherokee Nation Health Services; J.A. James, MD, PhD, Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation and Departments of Medicine, Pathology, and Microbiology/Immunology, University of Oklahoma Health Sciences Center. Address correspondence to Dr. J.A. James, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA. E-mail: judith-james@omrf.org Accepted for publication June 4, 2012.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Rheumatic Disease Among Oklahoma Tribal Populations: A Cross-sectional Study
Jasmine R. Gaddy, Evan S. Vista, Julie M. Robertson, Amy B. Dedeke, Virginia C. Roberts, Wendy S. Klein, Jeremy H. Levin, Fabio H. Mota, Tina M. Cooper, Gloria A. Grim, Sohail Khan, Judith A. James
The Journal of Rheumatology Aug 2012, jrheum.110984; DOI: 10.3899/jrheum.110984
Rheumatic Disease Among Oklahoma Tribal Populations: A Cross-sectional Study
Jasmine R. Gaddy, Evan S. Vista, Julie M. Robertson, Amy B. Dedeke, Virginia C. Roberts, Wendy S. Klein, Jeremy H. Levin, Fabio H. Mota, Tina M. Cooper, Gloria A. Grim, Sohail Khan, Judith A. James
The Journal of Rheumatology Aug 2012, jrheum.110984; DOI: 10.3899/jrheum.110984